We are proud, that after obtaining ethical approval, the following clinical sites are open for patient recruitment in our RAG1-SCID clinical trial:

- Leiden University Medical Center, Leiden, the Netherlands (RECOMB partner)

- Fundació Hospital Universitari Vall d’Hebron- Institut de Recerca, Barcelona, Spain (RECOMB partner)

- Wroclaw Medical University, Wroclaw, Poland (RECOMB partner)

- University College London Great Ormond Street Institute of Child Health, London, UK (RECOMB partner)

- Erciyes Üniversitesi TIP Fakültesi, Keyseri, Turkey (non-RECOMB partner)

- Children's Cancer Centre, The Royal Childrens Hospital, Melbourne, Australia (non-RECOMB partner)

Contact details of these sites can be found here.